Surface Oncology

$1.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-3.92%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SURF and other stocks, options, ETFs, and crypto commission-free!

About SURF

Surface Oncology, Inc. Common Stock, also called Surface Oncology, is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. Read More The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.

Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
54.60M
Price-Earnings Ratio
Dividend Yield
Average Volume
15.72K
High Today
$2.22
Low Today
$1.95
Open Price
$2.05
Volume
7.09K
52 Week High
$12.65
52 Week Low
$1.95

Collections

SURF Earnings

-$0.76
-$0.16
$0.45
$1.05
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 12, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.